Back to Search
Start Over
No Evidence for the In Vivo Induction of Genomic Instability by Low Doses of CS Gamma Rays in Bone Marrow Cells of BALB/CJ and C57BL/6J Mice.
- Source :
-
Dose-response : a publication of International Hormesis Society [Dose Response] 2012; Vol. 10 (1), pp. 11-36. Date of Electronic Publication: 2011 Aug 11. - Publication Year :
- 2012
-
Abstract
- In spite of extensive research, assessment of potential health risks associated with exposure to low-dose (≤ 0.1 Gy) radiation is still challenging. We evaluated the in vivo induction of genomic instability, expressed as late-occurring chromosome aberrations, in bone-marrow cells of two strains of mouse with different genetic background, i.e. the radiosensitive BALB/cJ and the radioresistant C57BL/6J strains following a whole-body exposure to varying doses of (137)Cs gamma rays (0, 0.05, 0.1, and 1.0 Gy). A total of five mice per dose per strain were sacrificed at various times post-irradiation up to 6 months for sample collections. Three-color fluorescence in situ hybridization for mouse chromosomes 1, 2, and 3 was used for the analysis of stable-aberrations in metaphase-cells. All other visible gross structural-abnormalities involving non-painted-chromosomes were also evaluated on the same metaphase-cells used for scoring the stable-aberrations of painted-chromosomes. Our new data demonstrated in bone-marrow cells from both strains that low doses of low LET-radiation (as low as 0.05 Gy) are incapable of inducing genomic instability but are capable of reducing specific aberration-types below the spontaneous rate with time post-irradiation. However, the results showed the induction of genomic instability by 1.0 Gy of (137)Cs gamma rays in the radiosensitive strain only.
Details
- Language :
- English
- ISSN :
- 1559-3258
- Volume :
- 10
- Issue :
- 1
- Database :
- MEDLINE
- Journal :
- Dose-response : a publication of International Hormesis Society
- Publication Type :
- Academic Journal
- Accession number :
- 22423226
- Full Text :
- https://doi.org/10.2203/dose-response.11-002.Rithidech